Bayer AG
393 articles about Bayer AG
-
Bayer AG Submits VEGF Trap-Eye (aflibercept solution for injection) for Treatment of Diabetic Macular Edema in the EU
11/7/2013
-
Bombay HC to Begin Hearing in Bayer AG's Case Against IPAB's CL Order on Nexavar Today
10/29/2013
-
Miguel Sieler, Former Chairman and C.E.O of Bayer France, Named C.E.O of Neovacs SA
10/18/2013
-
The Real Erin Brockovich Takes on Bayer AG's Birth Control
10/17/2013
-
Former Bayer AG Employee Can Proceed With Whistleblower Lawsuit
10/16/2013
-
BioInvent and Bayer AG Extend and Broaden Collaboration for the Discovery and Development of Therapeutic Antibodies
10/14/2013
-
Bayer AG Expects Five Drugs to Enter Phase 3 in 2015
10/8/2013
-
Bayer AG Snags Pfizer Inc. Exec for Head of Healthcare Post
9/30/2013
-
Bayer AG Grabs Approval for Adempas® as First Drug to Treat Rare Heart and Lung Disease
9/24/2013
-
Bayer AG Needs to Cut Costs: CEO Says
9/17/2013
-
Chinese Authorities Probing German Drugmaker Bayer AG
9/13/2013
-
Reports of Side-Effects, Deaths From Bayer AG's Xarelto Grow
9/10/2013
-
Bayer AG to Hire 800 in Russia Over the Next Four Years
9/10/2013
-
Bayer AG's Stivarga® (regorafenib) Tablets Approved in Europe
8/30/2013
-
Bayer AG and Onyx Pharmaceuticals, Inc.'s Nexavar Score FDA Priority Review as Thyroid Cancer Drug
8/27/2013
-
Bayer AG's Stivarga Approved for Further Indication in Japan
8/21/2013
-
FDA Reviewers Recommend Approval of Bayer AG Hypertension Drug But at Lower Doses
8/5/2013
-
Compugen Ltd. Bags Cancer Deal Worth $540 MIllion With Bayer AG
8/5/2013
-
Bayer AG Stock Rises as New Drugs Propel Revenue Increases
7/31/2013
-
A Bayer AG Drug, the European Medicines Agency and Transparency... or the Lack Thereof
7/11/2013